Inozyme Pharma Inc (INZY)
4.605
-0.12
(-2.64%)
USD |
NASDAQ |
May 17, 16:00
4.605
0.00 (0.00%)
After-Hours: 16:33
Inozyme Pharma Shareholders Equity (Quarterly): 118.84M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 118.84M |
| December 31, 2023 | 140.48M |
| September 30, 2023 | 160.21M |
| June 30, 2023 | 105.59M |
| March 31, 2023 | 103.35M |
| December 31, 2022 | 118.39M |
| September 30, 2022 | 134.78M |
| June 30, 2022 | 149.18M |
| March 31, 2022 | 94.23M |
| Date | Value |
|---|---|
| December 31, 2021 | 109.27M |
| September 30, 2021 | 125.97M |
| June 30, 2021 | 138.27M |
| March 31, 2021 | 148.89M |
| December 31, 2020 | 158.10M |
| September 30, 2020 | 167.92M |
| June 30, 2020 | -50.02M |
| March 31, 2020 | 70.83M |
| December 31, 2019 | -33.22M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-50.02M
Minimum
Jun 2020
167.92M
Maximum
Sep 2020
108.95M
Average
122.40M
Median
Shareholders Equity (Quarterly) Benchmarks
| Xeris Biopharma Holdings Inc | -9.178M |
| Kodiak Sciences Inc | 265.78M |
| Phathom Pharmaceuticals Inc | -148.50M |
| Athira Pharma Inc | 130.19M |
| Disc Medicine Inc | 338.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 176.94M |
| Total Liabilities (Quarterly) | 58.11M |